Inhibition of Poly-(ADP-Ribose) Polymerase Protects the Kidney in a Canine Model of Endotoxic Shock

Nephron

Volumn 130, Issue 4, 2015, Pages 281-292

  Liu, Si Bo ^a   Liu, Jinjie ^a   Liu, Da Wei ^b   Wang, Xiao Ting ^b   Yang, Rong Li ^a  

^a Dalian Municipal Central Hospital   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

3 aminobenzamide; Acute kidney injury; Apoptosis; Endotoxic shock; Hemodynamics; PARP

Indexed keywords

3-AMINOBENZAMIDE; BENZAMIDE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

ANIMAL; APOPTOSIS; DOG; DRUG EFFECTS; ENERGY METABOLISM; ENZYME ACTIVATION; HEMODYNAMICS; KIDNEY; KIDNEY CIRCULATION; KIDNEY TUBULE; MALE; OXYGEN CONSUMPTION; PATHOLOGY; SHOCK, SEPTIC;

ANIMALS; APOPTOSIS; BENZAMIDES; DOGS; ENERGY METABOLISM; ENZYME ACTIVATION; HEMODYNAMICS; KIDNEY; KIDNEY TUBULES; MALE; OXYGEN CONSUMPTION; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; RENAL CIRCULATION; SHOCK, SEPTIC;

EID: 84969695696     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000435815     Document Type: Article

References (36)

1. Singh AP, Junemann A, Muthuraman A, Jaggi AS, Singh N, Grover K, et al: Animal models of acute renal failure. Pharmacol Rep 2012; 64: 31-44.
2. Baitello AL, Marcatto G, Yagi RK: Risk factors for injury acute renal in patients with severe trauma and its effect on mortality. J Bras Nefrol 2013; 35: 127-131.
3. Ricci Z, Ronco C: New insights in acute kidney failure in the critically ill. Swiss Med Wkly 2012; 142:w13662.
4. Kinsey GR, Okusa MD: Expanding role of T cells in acute kidney injury. Curr Opin Nephrol Hypertens 2014; 23: 9-16.
5. Bomsztyk K, Denisenko O: Epigenetic alterations in acute kidney injury. Semin Nephrol 2013; 33: 327-340.
6. Zheng J, Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ: Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 2005; 288:F387-F398.
7. Filipovic DM, Meng X, Reeves WB: Inhibition of PARP prevents oxidant-induced necrosis but not apoptosis in LLC-PK1 cells. Am J Physiol 1999; 277:F428-F436.
8. Citarelli M, Teotia S, Lamb RS: Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes. BMC Evol Biol 2010; 10: 308.
9. Ta LE, Schmelzer JD, Bieber AJ, Loprinzi CL, Sieck GC, Brederson JD, et al: A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy. PLoS One 2013; 8: e54161.
10. Gerö D, Szabó C: Poly(ADP-ribose) polymerase: a new therapeutic target? Curr Opin Anaesthesiol 2008; 21: 111-121.
11. Musumeci G, Castrogiovanni P, Loreto C, Castorina S, Pichler K, Weinberg AM: Posttraumatic caspase-3 expression in the adjacent areas of growth plate injury site: a morphological study. Int J Mol Sci 2013; 14: 15767-15784.
12. Morotomi-Yano K, Akiyama H, Yano K: Nanosecond pulsed electric fields induce poly(ADP-ribose) formation and non-apoptotic cell death in HeLa S3 cells. Biochem Biophys Res Commun 2013; 438: 557-562.
13. Berger NA: Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 1985; 101: 4-15.
14. Yuksel BC, Serdar SE, Tuncel A, Uzum N, Ataoglu O, Atan A, et al: Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock. Eur Surg Res 2009; 43: 219-227.
15. Lobo SM, Orrico SR, Queiroz MM, Cunrath GS, Chibeni GS, Contrin LM, et al: Pneumonia-induced sepsis and gut injury: effects of a poly-(ADP-ribose) polymerase inhibitor. J Surg Res 2005; 129: 292-297.
16. Yang RL, Wang XT, Liu DW, Liu SB: Energy and oxygen metabolism disorder during septic acute kidney injury. Kidney Blood Press Res 2014; 39: 240-251.
17. Di Giantomasso D, Morimatsu H, May CN, Bellomo R: Intrarenal blood flow distribution in hyperdynamic septic shock: effect of norepinephrine. Crit Care Med 2003; 31: 2509-2513.
18. Tas Hekimoglu A, Toprak G, Akkoc H, Evliyaoglu O, Tas T, Kelle I, Colpan L: Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase in distant liver injury induced by renal ischemia-reperfusion in rats. Eur Rev Med Pharmacol Sci 2014; 18: 34-38.
19. Guzman JA, Rosado AE, Kruse JA: Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol (1985) 2003; 95: 803-809.
20. Dalaklioglu S, Tekcan M, Gungor NE, Celik-Ozenci C, Aksoy NH, Baykal A, Tasatargil A: Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury. Toxicol Lett 2010; 192: 91-96.
21. Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK: Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 2012; 40: 2997-3006.
22. Choi HM, Jo SK, Kim SH, Lee JW, Cho E, Hyun YY, Cha JJ, Kang YS, Cha DR, Cho WY, Kim HK: Glucocorticoids attenuate septic acute kidney injury. Biochem Biophys Res Commun 2013; 435: 678-684.
23. Koçkara A, Kayatas M: Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury. Ren Fail 2013; 35: 291-294.
24. Evans RG, Ince C, Joles JA, Smith DW, May CN, O'Connor PM, et al: Haemodynamic influences on kidney oxygenation: clinical implications of integrative physiology. Clin Exp Pharmacol Physiol 2013; 40: 106-122.
25. Evgenov OV, Liaudet L: Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock. Curr Vasc Pharmacol 2005; 3: 293-299.
26. Walsh SK, English FA, Crocker IP, Johns EJ, Kenny LC: Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia. Br J Pharmacol 2012; 166: 2109-2116.
27. Goldfarb RD, Marton A, Szabó E, Virág L, Salzman AL, Glock D, et al: Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 2002; 30: 974-980.
28. Iványi Z, Hauser B, Pittner A, Asfar P, Vassilev D, Nalos M, et al: Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia. Shock 2003; 19: 415-421.
29. Hans CP, Feng Y, Naura AS, Troxclair D, Zerfaoui M, Siddiqui D, et al: Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy. Cardiovasc Pathol 2011; 20:e57-e68.
30. Oztas E, Guven A, Turk E, Uysal B, Akgul EO, Cayci T, et al: 3-aminobenzamide, a poly ADP ribose polymerase inhibitor, attenuates renal ischemia/reperfusion injury. Ren Fail 2009; 31: 393-399.
31. Dalaklioglu S, Tekcan M, Gungor NE, Celik-Ozenci C, Aksoy NH, Baykal A, et al: Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury. Toxicol Lett 2010; 192: 91-96.
32. Choudhury S, Bae S, Ke Q, Lee JY, Kim J, Kang PM: Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion. Basic Res Cardiol 2011; 106: 397-407.
33. Szántó M, Rutkai I, Hegedus C, Czikora Á, Rózsahegyi M, Kiss B, et al: Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicininduced damage through SIRT1 induction. Cardiovasc Res 2011; 92: 430-438.
34. Gebhard C, Stähli BE, Shi Y, Camici GG, Akhmedov A, Hoegger L, et al: Poly(ADP-ribose) polymerase-1 protects from oxidative stress induced endothelial dysfunction. Biochem Biophys Res Commun 2011; 414: 641-646.
35. Sosna J, Voigt S, Mathieu S, Kabelitz D, Trad A, Janssen O, et al: The proteases HtrA2/ Omi and UCH-L1 regulate TNF-induced necroptosis. Cell Commun Signal 2013; 11: 76.
36. Yao K, Heyne N, Erley CM, Risler T, Osswald H: The selective adenosine A1 receptor antagonist KW-3902 prevents radiocontrast media-induced nephropathy in rats with chronic nitric oxide deficiency. Eur J Pharmacol 2001; 414: 99-104.